Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14 may promote neurodegeneration.
LATEST NEWS
- Neuro-Bio visits Munich for the Brain-Nose Symposium, hosted by Noselab!
- Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield attends DC Finance’s Global Family Office & High Net Worth Community 2025 London Conference
- Meeting with Prof. Lorna Harries at the University of Exeter to review progress and plan next experiments
- Our Office Manager Charles Monro attended the new opening of the reception area at UK Atomic Energy Authority
- Neuro-Bio welcomes back Adam Khan